INCIDENCE AND RATIONALE FOR P2Y12 INHIBITOR SWITCHING IN PATIENTS WITHIN 1 YEAR OF PERCUTANEOUS CORONARY INTERVENTION

MLA

Fu, A., et al. “Incidence and Rationale for P2y12 Inhibitor Switching in Patients within 1 Year of Percutaneous Coronary Intervention.” Canadian Journal of Cardiology, vol. 34, no. 10, Number 10 Supplement 1, Oct. 2018, p. S107. EBSCOhost, https://doi.org/10.1016/j.cjca.2018.07.245.

APA

Fu, A., Barry, Q., Boudreau, R., Perry-Nguyen, D., Tran, U., Simard, T., Le May, M., Labinaz, M., Dick, A., Glover, C., Froeschl, M., Hibbert, B., Chong, A., & So, D. (2018). Incidence and Rationale for P2y12 Inhibitor Switching in Patients within 1 Year of Percutaneous Coronary Intervention. Canadian Journal of Cardiology, 34(10, Number 10 Supplement 1), S107. https://doi.org/10.1016/j.cjca.2018.07.245

Chicago

Fu, A., Q. Barry, R. Boudreau, D. Perry-Nguyen, U. Tran, T. Simard, M. Le May, et al. 2018. “Incidence and Rationale for P2y12 Inhibitor Switching in Patients within 1 Year of Percutaneous Coronary Intervention.” Canadian Journal of Cardiology 34 (10, Number 10 Supplement 1): S107. doi:10.1016/j.cjca.2018.07.245.